These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38429901)

  • 1. STRN3 promotes tumour growth in hepatocellular carcinoma by inhibiting the hippo pathway.
    Zhu J; Tang W; Fang P; Wang C; Gu M; Yang W; Pan B; Wang B; Guo W
    J Cell Mol Med; 2024 Mar; 28(6):e18147. PubMed ID: 38429901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway.
    Yang J; Zhang X; Liu L; Yang X; Qian Q; Du B
    Life Sci; 2021 Jan; 264():118711. PubMed ID: 33186566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEPT6 drives hepatocellular carcinoma cell proliferation, migration and invasion via the Hippo/YAP signaling pathway.
    Fan Y; Du Z; Ding Q; Zhang J; Op Den Winkel M; Gerbes AL; Liu M; Steib CJ
    Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33846777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric Cancer.
    Tang Y; Fang G; Guo F; Zhang H; Chen X; An L; Chen M; Zhou L; Wang W; Ye T; Zhou L; Nie P; Yu H; Lin M; Zhao Y; Lin X; Yuan Z; Jiao S; Zhou Z
    Cancer Cell; 2020 Jul; 38(1):115-128.e9. PubMed ID: 32589942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal dehydrogenase 5 (RHD5) attenuates metastasis via regulating HIPPO/YAP signaling pathway in Hepatocellular Carcinoma.
    Hu H; Xu L; Luo SJ; Xiang T; Chen Y; Cao ZR; Zhang YJ; Mo Z; Wang Y; Meng DF; Yu L; Lin LZ; Zhang SJ
    Int J Med Sci; 2020; 17(13):1897-1908. PubMed ID: 32788868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
    Wang J; Fan Z; Li J; Yang J; Liu X; Cheng J
    Bioengineered; 2021 Dec; 12(1):3566-3577. PubMed ID: 34281492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sp2 promotes invasion and metastasis of hepatocellular carcinoma by targeting TRIB3 protein.
    Zhu Y; Cui J; Liu J; Hua W; Wei W; Sun G
    Cancer Med; 2020 May; 9(10):3592-3603. PubMed ID: 32160655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma.
    Zhang Y; Yan S; Chen J; Gan C; Chen D; Li Y; Wen J; Kremerskothen J; Chen S; Zhang J; Cao Y
    J Cell Mol Med; 2017 Dec; 21(12):3718-3729. PubMed ID: 28815883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
    Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
    Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma.
    Dong Q; Fu L; Zhao Y; Xie C; Li Q; Wang E
    Oncotarget; 2017 Feb; 8(9):15689-15703. PubMed ID: 28152516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway.
    Bao L; Yuan L; Li P; Bu Q; Guo A; Zhang H; Cui N; Liu B
    Cell Physiol Biochem; 2018; 50(2):437-451. PubMed ID: 30308519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
    Yan R; Liang ZW; Liu HS; Ge Y; An GY
    Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
    [No Abstract]   [Full Text] [Related]  

  • 13. LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling.
    Cheng Y; Hou T; Ping J; Chen T; Yin B
    J Exp Clin Cancer Res; 2018 Sep; 37(1):228. PubMed ID: 30219064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma.
    Ou H; Chen Z; Xiang L; Fang Y; Xu Y; Liu Q; Hu Z; Li X; Huang Y; Yang D
    Cancer Sci; 2019 Apr; 110(4):1169-1182. PubMed ID: 30677195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.
    Guan L; Li T; Ai N; Wang W; He B; Bai Y; Yu Z; Li M; Dong S; Zhu Q; Ding XX; Zhang S; Li M; Tang G; Xia X; Zhao J; Lin S; Yao S; Zhang L; Chen G; Liu FE; Li X; Zhang H
    J Exp Clin Cancer Res; 2019 Oct; 38(1):417. PubMed ID: 31623651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of Striatin 3 and MAP4K4 promotes growth and tissue invasion.
    Migliavacca J; Züllig B; Capdeville C; Grotzer MA; Baumgartner M
    Commun Biol; 2022 Aug; 5(1):795. PubMed ID: 35941177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ.
    Hao X; Zhang Y; Shi X; Liu H; Zheng Z; Han G; Rong D; Zhang C; Tang W; Wang X
    J Exp Clin Cancer Res; 2022 Sep; 41(1):281. PubMed ID: 36131287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of SSR2 Enhances Hepatocellular Carcinoma Cisplatin Sensitivity via the Hippo Pathway.
    Ye R; Yin L; Ge Y; Zhu X; Xiao Y; Fang C; Liu Q; Zhang H; Li H; Xie B
    Front Biosci (Landmark Ed); 2024 Aug; 29(8):299. PubMed ID: 39206890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EIF4A3-Induced Upregulation of hsa_circ_0049396 Attenuates the Tumorigenesis of Nasopharyngeal Carcinoma by Regulating the Hippo-YAP Pathway.
    Zhou Q; Cai B; Liu K; Chen H
    DNA Cell Biol; 2024 Oct; 43(10):510-519. PubMed ID: 39133108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.